Market Cap: $558.97M
FI
Fulgent Genetics, Inc.
FLGT
NASDAQ (NASDAQ Global Market)USD
Market Cap: $558.97M
Fulgent Genetics: A Promising Fourth Quarter Earnings Report Highlights Resilience and Growth Fulgent Genetics (NASDAQ: FLGT) announces a robust performance in its fourth-quarter earnings report relea…
Fulgent Genetics Gears Up for Future Growth with Robust Q4 Performance Fulgent Genetics, a notable entity in the genetic testing arena, releases its fourth-quarter earnings report on February 27, 2026…
Fulgent Genetics Prepares for Critical Earnings Report Amid Industry Evolution Fulgent Genetics is on the brink of announcing its quarterly earnings on November 7, 2025, a pivotal event for the compan…
Fulgent Genetics Prepares for Key Earnings Report Amidst Evolving Market Landscape Fulgent Genetics, a prominent player in the genetics and diagnostics industry, is poised to announce its quarterly ea…
Fulgent Genetics: Pioneering Personalized Medicine in Oncology Fulgent Genetics continues to establish itself as a leader in the field of personalized medicine through its innovative genetic testing s…
Fulgent Genetics: Pioneering Innovations in Oncology Testing Amidst Market Challenges Fulgent Genetics continues to position itself at the forefront of oncology testing by leveraging advanced technolo…
Fulgent Genetics Faces Competitive Landscape in Oncology Testing Amid Market Developments As the landscape of oncology testing evolves, companies like Fulgent Genetics are navigating a complex environ…
Fulgent Genetics Focuses on Strategic Service Enhancements Amidst Healthcare Evolution Fulgent Genetics continues to navigate the rapidly changing landscape of the healthcare industry, particularly in…
Fulgent Genetics: Pioneering Innovations in Genetic Testing Amidst a Competitive Landscape Fulgent Genetics stands at the forefront of the rapidly evolving genetic testing industry, focusing on the in…
Fulgent Genetics Positions for Expansion in Genetic Testing Market Fulgent Genetics, a leader in genetic testing and diagnostics, is poised to leverage its innovative capabilities as the demand for ge…
Fulgent Genetics Prepares for Quarterly Earnings Report Amid Evolving Diagnostics Landscape Fulgent Genetics (FLGT) is poised to release its quarterly earnings report on August 1, 2025, a critical eve…
Fulgent Genetics Prepares for Key Earnings Announcement Amidst Evolving Landscape Fulgent Genetics (FLGT) is poised to unveil its quarterly earnings report on August 1, 2025, an event that holds signi…
Fulgent Genetics: Pioneering Precision Medicine in Oncology Fulgent Genetics, Inc., a technology-driven leader in genetic testing and diagnostics, is poised to transform its operational focus as it re…
### Fulgent Genetics Partners with Foundation Medicine to Enhance Cancer Risk Assessment Fulgent Genetics, a prominent player in genomic testing, collaborates with Foundation Medicine, Inc. to launch…
Foundation Medicine and Fulgent Genetics Join Forces to Enhance Cancer Risk Assessment Foundation Medicine, Inc. announces the impending launch of two innovative germline tests aimed at revolutionizin…
Fulgent Genetics Reports Strong Growth in Laboratory Services Amid Financial Losses Fulgent Genetics, Inc., a technology-driven company specializing in laboratory services and therapeutic development,…